Herbas VPB

Print
EN | LT
LT - Junginiai ir būdai, skirti NHE-medijuoto antiporto slopinimui, gydant sutrikimus, susijusius su skysčių kaupimusi ir druskų pertekliumi, bei virškinamojo trakto sutrikimus
EN - COMPOUNDS AND METHODS FOR INHIBITING NHE-MEDIATED ANTIPORT IN THE TREATMENT OF DISORDERS ASSOCIATED WITH FLUID RETENTION OR SALT OVERLOAD AND GASTROINTESTINAL TRACT DISORDERS

Legal status

Patent in force

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C07C 311/29 (2006.01)
C07D 217/04 (2006.01)
C07D 401/12 (2006.01)
C07F 9/38 (2006.01)
C07F 9/40 (2006.01)
C07F 9/572 (2006.01)
C07F 9/62 (2006.01)
A61K 31/18 (2006.01)
A61K 31/472 (2006.01)
A61K 31/4725 (2006.01)
A61K 31/517 (2006.01)
A61K 31/662 (2006.01)
A61K 31/675 (2006.01)
A61K 45/06 (2006.01)
A61K 47/54 (2017.01)
A61P 1/06 (2006.01)
A61P 13/12 (2006.01)
European patent
(11) Number of the document 2384318
(13) Kind of document T
(96) European patent application number 09796924.0
Date of filing the European patent application 2009-12-30
(97) Date of publication of the European application 2011-11-09
(45) Date of publication and mention of the grant of the patent 2017-11-15
(46) Date of publication of the claims translation 2018-02-26
PCT application
(86) Number PCT/US2009/069852
Date 2009-12-30
PCT application publication
(87) Number WO 2010/078449
Date 2010-07-08
Priority applications
(30) Number Date Country code
141853 P 2008-12-31 US
169509 P 2009-04-15 US
237842 P 2009-08-28 US
Inventors
(72)
CHARMOT, Dominique, US
JACOBS, Jeffrey, W., US
LEADBETTER, Michael, Robert, US
NAVRE, Marc, US
CARRERAS, Chris, US
BELL, Noah, US
Grantee
(73) Ardelyx, Inc., 34175 Ardenwood Blvd., Fremont, California 94555, US
Attorney or representative
(74) Stanislava TELEIŠIENĖ, UAB "Brainera", Taikos 235-17, LT-05213 Vilnius, LT
Title
(54) Junginiai ir būdai, skirti NHE-medijuoto antiporto slopinimui, gydant sutrikimus, susijusius su skysčių kaupimusi ir druskų pertekliumi, bei virškinamojo trakto sutrikimus
  COMPOUNDS AND METHODS FOR INHIBITING NHE-MEDIATED ANTIPORT IN THE TREATMENT OF DISORDERS ASSOCIATED WITH FLUID RETENTION OR SALT OVERLOAD AND GASTROINTESTINAL TRACT DISORDERS
Last renewal fee
Payment date Validity (years) Amount
2024-12-03 16 347.00 EUR
Next renewal fee
2025-12-30